Abstract
The sphingolipid ceramide has recently emerged as a new transducer or modulator of apoptotic cell death. This function, however, has recently been challenged. Here, in the light of recent observations, the role of ceramide in apoptosis signaling is discussed.
Similar content being viewed by others
REFERENCES
Hengartner, M. O. 2000. The biochemistry of apoptosis. Nature 407:770-776.
Riboni, L., Viani, P., Bassi, R., Prinetti, A., and Tettamanti, G. 1997. The role of sphingolipids in the process of signal transduction. Prog. Lipid Res. 36:153-195.
Kolesnick, R. N. and Krönke, M. 1998. Regulation of ceramide production and apoptosis. Annu. Rev. Physiol. 60:643-665.
Hannun, Y. A. and Luberto, C. 2000. Ceramide in the eukaryotic stress response. Trends Cell Biol. 10:73-80.
Obeid, L. M., Linardic, C. M., Karolak, L. A., and Hannun, Y. A. 1993. Programmed cell death induced by ceramide. Science 259:1769-1771.
Hofmann, K. and Dixit, V. M. 1998. Ceramide in apoptosis: does it really matter? Trends Biochem. Sci. 23:374-377.
Kolesnick, R. and Hannun, Y. A. 1999. Ceramide and apoptosis. Trends Biochem. Sci. 24:224-225.
Hofmann, K. and Dixit, V. M. 1999. Reply to Kolesnick and Hannun, and Perry and Hannun. Trends Biochem. Sci. 24:227.
Radin, N. S. 2001. Killing cancer cells by poly-drug elevation of ceramide levels: a hypothesis whose time has come? Eur. J. Biochem. 268:193-204.
Hannun, Y. A., Luberto, C., and Argraves, K. M. 2001. Enzymes of sphingolipid metabolism: from modular to integrative signaling. Biochemistry 40:4893-4903.
Levade, T., Augé, N., Veldman, R. J., Cuvillier, O., Nègre-Salvayre, A., and Salvayre, R. 2001. Sphingolipid mediators in cardiovascular cell biology and pathology. Circ. Res. 89:957-968.
Mathias, S., Pena, L. A., and Kolesnick, R. N. 1998. Signal transduction of stress via ceramide. Biochem. J. 335:465-480.
Zhang, J., Alter, N., Reed, J. C., Borner, C., Obeid, L. M., and Hannun, Y. A. 1996. Bcl-2 interrupts the ceramide-mediated pathway of cell death. Proc. Natl. Acad. Sci. U.S.A. 93:5325-5328.
Allouche, M., Bettaieb, A., Vindis, C., Rousse, A., Grignon, C., and Laurent, G. 1997. Influence of Bcl-2 overexpression on the ceramide pathway in daunorubicin-induced apoptosis of leukemic cells. Oncogene 14:1837-1845.
Dbaibo, G. S., Perry, D. K., Gamard, C. J., Platt, R., Poirier, G. G., Obeid, L. M., and Hannun, Y. A. 1997. Cytokine response modifier A (CrmA) inhibits ceramide formation in response to tumor necrosis factor (TNF)-α: CrmA and Bcl-2 target distinct components in the apoptotic pathway. J. Exp. Med. 185:481-490.
Wiesner, D. A., Kilkus, J. P., Gottschalk, A. R., Quintans, J., and Dawson, G. 1997. Anti-immunoglobulin-induced apoptosis in WEHI 231 cells involve the slow formation of ceramide from sphingomyelin and is blocked by bcl-XL. J. Biol. Chem. 272: 9868-9876.
Jaffrézou, J. P., Maestre, N., de Mas-Mansat, V., Bezombes, C., Levade, T., and Laurent, G. 1998. Positive feedback control of neutral sphingomyelinase activity by ceramide. FASEB J. 12: 999-1006.
Tepper, A. D., de Vries, E., van Blitterswijk, W. J., and Borst, J. 1999. Ordering of ceramide formation, caspase activation, and mitochondrial changes during CD95-and DNA damageinduced apoptosis. J. Clin. Invest. 103:971-978.
Cuvillier, O., Edsall, L., and Spiegel, S. 2000. Involvement of sphingosine in mitochondria-dependent Fas-induced apoptosis of type II Jurkat T cells. J. Biol. Chem. 275:15691-15700.
Ji, L., Zhang, G., Uematsu, S., Akahori, Y., and Hirabayashi, Y. 1995. Induction of apoptotic DNA fragmentation and cell death by natural ceramide. FEBS Lett. 358:211-214.
Sweeney, E. A., Sakakura, C., Shirahama, T., Masamune, A., Ohta, H., Hakomori, S., and Igarashi, Y. 1996. Sphingosine and its methylated derivative N,N-dimethylsphingosine (DMS) induce apoptosis in a variety of human cancer cell lines. Int. J. Cancer 66:358-366.
Bielawska, A., Crane, H. M., Liotta, D., Obeid, L. M., and Hannun, Y. A. 1993. Selectivity of ceramide-mediated biology. Lack of activity of erythro-dihydroceramide. J. Biol. Chem. 268:26226-26232.
Zhang, P., Liu, B., Jenkins, G. M., Hannun, Y. A., and Obeid, L. M. 1997. Expression of neutral sphingomyelinase identifies a distinct pool of sphingomyelin involved in apoptosis. J. Biol. Chem. 272:9609-9612.
Birbes, H., El Bawab, S., Hannun, Y. A., and Obeid, L. M. 2001. Selective hydrolysis of a mitochondrial pool of sphingomyelin induces apoptosis. FASEB J. 15:2669-2679.
Kanto, T., Kalinski, P., Hunter, O. C., Lotze, M. T., and Amoscato, A. A. 2001. Ceramide mediates tumor-induced dendritic cell apoptosis. J. Immunol. 167:3773-3784.
Selzner, M., Bielawska, A., Morse, M. A., Rudiger, H. A., Sindram, D., Hannun, Y. A., and Clavien, P. A. 2001. Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer. Cancer Res. 61:1233-1240.
Nicholson, K. M., Quinn, D. M., Kellett, G. L., and Warr, J. R. 1999. Preferential killing of multidrug-resistant KB cells by inhibitors of glucosylceramide synthase. Br. J. Cancer 81:423-430.
Edsall, L. C., Pirianov, G. G., and Spiegel, S. 1997. Involvement of sphingosine 1-phosphate in nerve growth factor-mediated neuronal survival and differentiation. J. Neurosci. 17:6952-6960.
Xia, P., Wang, L., Gamble, J. R., and Vadas, M. A. 1999. Activation of sphingosine kinase by tumor necrosis factor-alpha inhibits apoptosis in human endothelial cells. J. Biol. Chem. 274:34499-34505.
Mandala, S. M., Thornton, R., Galve-Roperh, I., Poulton, S., Peterson, C., Olivera, A., Bergstrom, J., Kurtz, M. B., and Spiegel, S. 2000. Molecular cloning and characterization of a lipid phosphohydrolase that degrades sphingosine-1-phosphate and induces cell death. Proc. Natl. Acad. Sci. U.S.A. 97:7859-7864.
Bose, R., Verheij, M., Haimovitz-Friedman, A., Scotto, K., Fuks, Z., and Kolesnick, R. 1995. Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell 82:405-414.
Xu, J., Yeh, C. H., Chen, S., He, L., Sensi, S. L., Canzoniero, L. M., Choi, D. W., and Hsu, C. Y. 1998. Involvement of de novo ceramide biosynthesis in tumor necrosis factor-alpha/ cycloheximide-induced cerebral endothelial cell death. J. Biol. Chem. 273:16521-16526.
Perry, D. K., Carton, J., Shah, A. K., Meredith, F., Uhlinger, D. J., and Hannun, Y. A. 2000. Serine palmitoyltransferase regulates de novo ceramide generation during etoposide-induced apoptosis. J. Biol. Chem. 275:9078-9084.
Kroesen, B. J., Pettus, B., Luberto, C., Busman, M., Sietsma, H., de Leij, L., and Hannun, Y. A. 2001. Induction of apoptosis through B-cell receptor cross-linking occurs via de novo generated C16-ceramide and involves mitochondria. J. Biol. Chem. 276:13606-13614.
Olivera, A., Kohama, T., Edsall, L., Nava, V., Cuvillier, O., Poulton, S., and Spiegel, S. 1999. Sphingosine kinase overexpression increases intracellular sphingosine-1-phosphate and promotes cell growth and survival. J. Cell. Biol. 147: 545-557.
Edsall, L., Cuvillier, O., Twitty, S., Spiegel, S., and Milstien, S. 2001. Sphingosine kinase expression regulates apoptosis and caspase activation in PC12 cells. J. Neurochem. 76:1573-1584.
Liu, Y. Y., Han, T. Y., Giuliano, A. E., and Cabot, M. C. 2001. Ceramide glycosylation potentiates cellular multidrug resistance. FASEB J. 15:719-730.
Higuchi, M., Singh, S., Jaffrézou, J. P., and Aggarwal, B. B. 1996. Acidic sphingomyelinase-generated ceramide is needed but not sufficient for TNF-induced apoptosis and nuclear factor κB activation. J. Immunol. 156:297-304.
Chen, J. K., Capdevila, J., and Harris, R. C. 2001. Cytochrome p450 epoxygenase metabolism of arachidonic acid inhibits apoptosis. Mol. Cell Biol. 21:6322-6331.
Brann, A. B., Tcherpakov, M., Williams, I. M., Futerman, A. H., and Fainzilber, M. 2002. NGF-induced p75-mediated death of cultured hippocampal neurons is age-dependent and transduced through ceramide generated by neutral sphingomyelinase. J. Biol. Chem. 277:9812-9818
Oses-Prieto, J. A., Lopez-Moratalla, N., Santiago, E., Jaffrézou, J. P., and Lopez-Zabalza, M. J. 2000. Molecular mechanisms of apoptosis induced by an immunomodulating peptide on human monocytes. Arch. Biochem. Biophys. 379:353-362.
Sawada, M., Nakashima, S., Kiyono, T., Yamada, J., Hara, S., Nakagawa, M., Shinoda, J., and Sakai, N. 2002. Acid sphingomyelinase activation requires caspase-8 but not p53 nor reactive oxygen species during Fas-induced apoptosis in human glioma cells. Exp. Cell Res. 273:157-168.
Ségui, B., Bezombes, C., Uro-Coste, E., Medin, J. A., Andrieu-Abadie, N., Augé, N., Brouchet, A., Laurent, G., Salvayre, R., Jaffrézou, J. P., and Levade, T. 2000. Stress-induced apoptosis is not mediated by endolysosomal ceramide. FASEB J. 14:36-47.
Burek, C., Roth, J., Koch, H. G., Harzer, K., Los, M., and Schulze-Osthoff, K. 2001. The role of ceramide in receptor-and stress-induced apoptosis studied in acidic ceramidase-deficient Farber disease cells. Oncogene 20:6493-6502.
Luberto, C., Toffaletti, D. L., Wills, E. A., Tucker, S. C., Casadevall, A., Perfect, J. R., Hannun, Y. A., and Del Poeta, M. M. 2001. Roles for inositol-phosphoryl ceramide synthase 1 (IPC1) in pathogenesis of C. neoformans. Genes Dev. 15:201-212.
Cheng, J., Park, T. S., Fischl, A. S., and Ye, X. S. 2001. Cell cycle progression and cell polarity require sphingolipid biosynthesis in Aspergillus nidulans. Mol. Cell Biol. 21:6198-6209.
Pronk, G. J., Ramer, K., Amiri, P., and Williams, L. T. 1996. Requirement of an ICE-like protease for induction of apoptosis and ceramide generation by REAPER. Science, 271:808-810.
Adachi-Yamada, T., Gotoh, T., Sugimura, I., Tateno, M., Nishida, Y., Onuki, T., and Date, H. 1999. De novo synthesis of sphingolipids is required for cell survival by down-regulating c-Jun N-terminal kinase in Drosophila imaginal discs. Mol. Cell Biol. 19:7276-8726.
Wright, S. C., Zheng, H., and Zhong, J. 1996. Tumor cell resistance to apoptosis due to a defect in the activation of sphingomyelinase and the 24 kDa apoptotic protease (AP24). FASEB J. 10:325-332.
Cai, Z., Bettaieb, A., El Mahdani, N., Legres, L. G., Stancou, R., Masliab, J., and Chouaib, S. 1997. Alteration of the sphingomyelin/ceramide pathway is associated with resistance of human breast carcinoma MCF7 cells to tumor necrosis factor-α-mediated cytotoxicity. J. Biol. Chem. 272:6918-6926.
Chmura, S. J., Nodzenski, E., Beckett, M. A., Kufe, D. W., Quintans, J., and Weichselbaum, R. R. 1997. Loss of ceramide production confers resistance to radiation-induced apoptosis. Cancer Res. 57:1270-1275.
Michael, J. M., Lavin, M. F., and Watters, D. J. 1997. Resistance to radiation-induced apoptosis in Burkitt's lymphoma cells is associated with defective ceramide signaling. Cancer Res. 57:3600-3605.
Bruno, A. P., Laurent, G., Averbeck, D., Demur, C., Bonnet, J., Bettaieb, A., Levade, T., and Jaffrézou, J. P. 1998. Lack of ceramide generation in TF-1 human myeloid leukemic cells resistant to ionizing radiation. Cell Death Differ. 5:172-182.
Wang, X. Z., Beebe, J. R., Pwiti, L., Bielawska, A., and Smyth, M. J. 1999. Aberrant sphingolipid signaling is involved in the resistance of prostate cancer cell lines to chemotherapy. Cancer Res. 59:5842-5848.
Nava, V. E., Cuvillier, O., Edsall, L. C., Kimura, K., Milstien, S., Gelmann, E. P., and Spiegel, S. 2000. Sphingosine enhances apoptosis of radiation-resistant prostate cancer cells. Cancer Res. 60:4468-4474.
Haimovitz-Friedman, A., Kan, C., Ehleiter, D., Persaud, R. S., McLoughlin, M., Fuks, Z., and Kolesnick, R. N. 1994. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J. Exp. Med. 180:525-535.
Jarvis, W. D., Fornari, F. A., Gewirtz, D. A., Kolesnick, R. N., and Grant, S. 1994. Attenuation of ceramide-induced apoptosis by diglyceride in human myeloid leukemia cells. J. Biol. Chem. 269:31685-31692.
Mansat, V., Laurent, G., Levade, T., Bettaieb, A., and Jaffrézou, J. P. 1997. The protein kinase C activators phorbol esters and phosphatidylserine inhibit neutral sphingomyelinase activation, ceramide generation, and apoptosis triggered by daunorubicin. Cancer Res. 57:5300-5304.
Pena, L. A., Fuks, Z., and Kolesnick, R. N. 2000. Radiation-induced apoptosis of endothelial cells in the murine central nervous system: protection by fibroblast growth factor and sphingomyelinase deficiency. Cancer Res. 60:321-327.
Paris, F., Fuks, Z., Kang, A., Capodieci, P., Juan, G., Ehleiter, D., Haimovitz-Friedman, A., Cordon-Cardo, C., and Kolesnick, R. 2001. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 293:293-297.
Bezombes, C., Maestre, N., Laurent, G., Levade, T., Bettaieb, A., and Jaffrézou, J. P. 1998. Restoration of TNF-α-induced ceramide generation and apoptosis in resistant human leukemia KG1a cells by the P-glycoprotein blocker PSC833. FASEB J. 12:101-109.
Senchenkov, A., Litvak, D. A., and Cabot, M. C. 2001. Targeting ceramide metabolism—a strategy for overcoming drug resistance. J. Natl. Cancer Inst. 93:347-357.
Santana, P., Pena, L. A., Haimovitz-Friedman, A., Martin, S., Green, D., McLoughlin, M., Cordon-Cardo, C., Schuchman, E. H., Fuks, Z., and Kolesnick, R. 1996. Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell 86:189-199.
Haimovitz-Friedman, A., Cordon-Cardo, C., Bayoumy, S., Garzotto, M., McLoughlin, M., Gallily, R., Edwards, C. K., Schuchman, E. H., Fuks, Z., and Kolesnick, R. 1997. Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J. Exp. Med. 186:1831-1841.
de Maria, R., Rippo, M. R., Schuchman, E. H., and Testi, R. 1998. Acidic sphingomyelinase (ASM) is necessary for Fas-induced GD3 ganglioside accumulation and efficient apoptosis of lymphoid cells. J. Exp. Med. 187:897-902.
Kirschnek, S., Paris, F., Weller, M., Grassme, H., Ferlinz, K., Riehle, A., Fuks, Z., Kolesnick, R., and Gulbins, E. 2000. CD95-mediated apoptosis in vivo involves acid sphingomyelinase. J. Biol. Chem. 275:27316-27323.
Lozano, J., Menendez, S., Morales, A., Ehleiter, D., Liao, W. C., Wagman, R., Haimovitz-Friedman, A., Fuks, Z., and Kolesnick, R. 2001. Cell autonomous apoptosis defects in acid sphingomyelinase knockout fibroblasts. J. Biol. Chem. 276:442-448.
Zhang, Y., Mattjus, P., Schmid, P. C., Dong, Z., Zhong, S., Ma, W. Y., Brown, R. E., Bode, A. M., and Schmid, H. H. 2001. Involvement of the acid sphingomyelinase pathway in UVA-induced apoptosis. J. Biol. Chem. 276:11775-11782.
Boesen de Cock, J. G. R., Tepper, A. D., de Vries, E., van Blitterswijk, W. J., and Borst, J. 1998. CD95 (Fas/APO-1) induces ceramide formation and apoptosis in the absence of a functional acid sphingomyelinase. J. Biol. Chem. 273:7560-7565.
Nix, M., and Stoffel, W. 2000. Perturbation of membrane microdomains reduces mitogenic signaling and increases susceptibility to apoptosis after T cell receptor stimulation. Cell Death Differ. 7:413-424.
Bezombes, C., Ségui, B., Cuvillier, O., Bruno, A. P., Uro-Coste, E., Gouazé, V., Andrieu-Abadie, N., Carpentier, S., Laurent, G., Salvayre, R., Jaffrézou, J. P., and Levade, T. 2001. Lysosomal sphingomyelinase is not solicited for apoptosis signaling. FASEB J. 15:297-299.
Wiegmann, K., Schütze, S., Machleidt, T., Witte, D., and Krönke, M. 1994. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 78: 1005-1015.
Cifone, M. G., Roncaioli, P., De Maria, R., Camarda, G., Santoni, A., Ruberti, G., and Testi, R. 1995. Multiple pathways originate at the Fas/APO-1 (CD95) receptor: sequential involvement of phosphatidylcholine-specific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal. EMBO J. 14:5859-5868.
Chinnaiyan, A. M., Tepper, C. G., Seldin, M. F., O'Rourke, K., Kischkel, F. C., Hellbardt, S., Krammer, P. H., Peter, M. E., and Dixit, V. M. 1996. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J. Biol. Chem. 271:4961-4965.
Levade, T. and Jaffrézou, J. P. 1999. Signalling sphingomyelinases: which, where, how and why? Biochim. Biophys. Acta. 1438:1-17.
Jayadev, S., Hayter, H. L., Andrieu, N., Gamard, C. J., Liu, B., Balu, R., Hayakawa, M., Ito, F., and Hannun, Y. A. 1997. Phospholipase A2 is necessary for tumor necrosis factor alpha-induced ceramide generation in L929 cells. J. Biol. Chem. 272:17196-17203.
Mansat, V., Bettaieb, A., Levade, T., Laurent, G., and Jaffrézou, J. P. 1997. Serine protease inhibitors block neutral sphingomyelinase activation, ceramide generation, and apoptosis triggered by daunorubicin. FASEB J. 11:695-702.
Bezombes, C., Plo, I., Mansat-De Mas, V., Quillet-Mary, A., Negre-Salvayre, A., Laurent, G., and Jaffrezou, J. P. 2001. Oxidative stress-induced activation of Lyn recruits sphingomyelinase and is requisite for its stimulation by Ara-C. FASEB J. 15:1583-1585.
Liu, B., Andrieu-Abadie, N., Levade, T., Zhang, P., Obeid, L. M. and Hannun, Y. A. 1998. Glutathione regulation of neutral sphingomyelinase in tumor necrosis factor-alpha-induced cell death. J. Biol. Chem. 273:11313-11320.
Gouazé, V., Mirault, M. E., Carpentier, S., Salvayre, R., Levade, T., and Andrieu-Abadie, N. 2001. Glutathione peroxidase-1 overexpression prevents ceramide production and partially inhibits apoptosis in doxorubicin-treated human breast carcinoma cells. Mol. Pharmacol. 60:488-496.
Adam, D., Wiegmann, K., Adam-Klages, S., Ruff, A., and Krönke, M. 1996. A novel cytoplasmic domain of the p55 Tumor Necrosis Factor receptor initiates the neutral sphingomyelinase pathway. J. Biol. Chem. 1996:14617-14622.
Adam-Klages, S., Adam, D., Wiegmann, K., Struve, S., Kolanus, W., Schneider-Mergener, J., and Krönke, M. 1996. FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase. Cell. 86:937-947.
Kreder, D., Krut, O., Adam-Klages, S., Wiegmann, K., Scherer, G., Plitz, T., Jensen, J. M., Proksch, E., Steinmann, J., Pfeffer, K., and Krönke, M. 1999. Impaired neutral sphingomyelinase activation and cutaneous barrier repair in FAN-deficient mice. EMBO J. 18:2472-2479.
Ségui, B., Andrieu-Abadie, N., Adam-Klages, S., Meilhac, O., Kreder, D., Garcia, V., Bruno, A. P., Jaffrézou, J. P., Salvayre, R., Krönke, M., and Levade, T. 1999. CD40 signals apoptosis through FAN-regulated activation of the sphingomyelin-ceramide pathway. J. Biol. Chem. 274:37251-37258.
Ségui, B., Cuvillier, O., Adam-Klages, S., Garcia, V., Malagarie-Cazenave, S., Lévêque, S., Caspar-Bauguil, S., Coudert, J., Salvayre, R., Krönke, M., and Levade, T. 2001. Involvement of FAN in tumor necrosis factor-induced apoptosis. J. Clin. Invest. 108:143-151.
Lee, T. C., Ou, M. C., Shinozaki, K., Malone, B., and Snyder, F. 1996. Biosynthesis of N-acetylsphingosine by plateletactivating factor: sphingosine CoA-independent transacetylase in HL-60 cells. J. Biol. Chem. 271:209-217.
Holopainen, J. M., Angelova, M. I., and Kinnunen, P. K. 2000. Vectorial budding of vesicles by asymmetrical enzymatic formation of ceramide in giant liposomes. Biophys. J. 78:830-838.
Kolesnick, R. N., Goni, F. M., and Alonso, A. 2000. Compartmentalization of ceramide signaling: physical foundations and biological effects. J. Cell Physiol. 184:285-300.
Zha, X., Pierini, L. M., Leopold, P. L., Skiba, P. J., Tabas, I., and Maxfield, F. R. 1998. Sphingomyelinase treatment induces ATP-independent endocytosis. J. Cell Biol. 140:39-47.
Cremesti, A., Paris, F., Grassme, H., Holler, N., Tschopp, J., Fuks, Z., Gulbins, E., and Kolesnick, R. 2001. Ceramide enables fas to cap and kill. J. Biol. Chem. 276:23954-23961.
Perry, D. K. and Hannun, Y. A. 1999. The use of diglyceride kinase for quantifying ceramide. Trends Biochem. Sci. 24: 226-227.
Kono, K., Tanaka, M., Ogita, T., Hosoya, T., and Kohama, T. 2000. F-12509A, a new sphingosine kinase inhibitor, produced by a discomycete. J. Antibiot. (Tokyo) 53:459-466.
Kono, K., Tanaka, M., Ogita, T., and Kohama, T. 2000. Characterization of B-5354c, a new sphingosine kinase inhibitor, produced by a marine bacterium. J. Antibiot. (Tokyo) 53: 759-764.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Levade, T., Malagarie-Cazenave, S., Gouazé, V. et al. Ceramide in Apoptosis: A Revisited Role. Neurochem Res 27, 601–607 (2002). https://doi.org/10.1023/A:1020215815013
Issue Date:
DOI: https://doi.org/10.1023/A:1020215815013